Skip to main content
. 1999 Oct;48(4):553–563. doi: 10.1046/j.1365-2125.1999.00051.x

Table 4.

Pharmacokinetic parameters of the active moiety (unbound tolterodine+the 5-hydroxymethyl metabolite) following treatment with tolterodine [as l-tartrate salt] 2 mg twice daily for 2.5 days in the absence and presence of fluoxetine (20 mg once daily for 27 days).

graphic file with name bcp0048-0553-t4.jpg